The core business at Vivolux is to identify and optimize novel compounds for cancer treatment. Vivolux has leading experts in chemistry, clinical pharmacology, mechanism of action studies, experimental and clinical oncology, clinical trials and regulatory affairs. The company has validated preclinical methods for the prediction of clinical success/failure. We are interested in exploring partnerships within the academic world and with commercial organizations. Some of our own substances with diagnostic properties can also be purchased. Below is a list of the reagents that are available.